Table 2 Primary and secondary outcomes evaluation
Outcomes | Numen N = 58 | Axium N = 66 | Odds ratio (95% Cl) | P value |
|---|---|---|---|---|
Success occlusion rate (6 M) | 54 (93.1%) | 64 (97.0%) | 0.208 (0.023–1.914) | 0.334 |
Immediate success occlusion rate | 51 (87.9%) | 62 (93.9%) | 0.470 (0.130–1.696) | 0.345 |
Complete occlusion rate | ||||
6 M | 37 (63.8%) | 41 (62.1%) | 1.384 (0.629–3.042) | 0.435 |
12 M | 38 (65.5%) | 44 (66.7%) | 1.234 (0.549–2.771) | 0.684 |
Recurrence rate | ||||
6 M | 3 (5.2%) | 2 (3.0%) | 1.788 (0.288–11.113) | 0.661 |
12 M | 4 (6.9%) | 3 (4.5%) | 1.595 (0.341–7.457) | 0.702 |
Ischemic stroke | ||||
1 M | 1 (1.7%) | 3 (4.5%) | 0.462 | |
General adverse events | ||||
1 M | 9 (15.5%) | 11 (16.7%) | 0.680 (0.351–2.402) | 0.905 |
6 M | 9 (15.5%) | 11 (16.7%) | 0.680 (0.351–2.402) | 0.905 |
12 M | 9 (15.5%) | 11 (16.7%) | 0.680 (0.351–2.402) | 0.905 |